Company Presentation January 2013 - Epigenomics AG
Company Presentation January 2013 - Epigenomics AG
Company Presentation January 2013 - Epigenomics AG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Epi proColon® 2.0: Powerful Screening Tool with Flexible Set Up<br />
34 | <strong>January</strong> <strong>2013</strong><br />
Method Specificity Sensitivity Positive<br />
Predictive Value 3)<br />
Epi proColon® 2.0 CE*<br />
(marketed in Europe) 1) 99.3% 80.6% 45.7%<br />
OC-Sensa Micro qFIT1x2 2) 93.7% 69.2% 7.5%<br />
1) Tetzner et al. UEGW 2011, 2 Allison et al. 1996 NEJM, 2) Park et al. 2010. Am. J. Gastro.<br />
3) Orange figure: CRC with positive test result, grey figure: healthy with positive test result assuming a prevalence for CRC of 0.7%.
Change language